Results 211 to 220 of about 113,709 (339)
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source
Pentoxazone (Second Edition) (Pesticides). [PDF]
Food Safety Commission of Japan.
europepmc +1 more source
Abstract Regulatory genetic toxicology focuses on DNA damage and subsequent gene mutations. However, genotoxic agents can also affect epigenetic marks, and incorporation of epigenetic data into the regulatory framework may thus enhance the accuracy of risk assessment.
Roger Godschalk +4 more
wiley +1 more source
Why rat oral cavity tumors should not be the basis of quantitative cancer risk assessment for oral exposure to hexavalent chromium. [PDF]
Proctor D +3 more
europepmc +1 more source
Lung carcinogenicity by whole body inhalation exposure to Anatase-type Nano-titanium Dioxide in rats
Tatsuya Kasai +10 more
openalex +2 more sources
Abstract In human health risk assessment of chemicals and pharmaceuticals, identification of genotoxicity hazard usually starts with a standard battery of in vitro genotoxicity tests, which is needed to cover all genotoxicity endpoints. The individual tests included in the battery are not designed to pick up all endpoints.
Mirjam Luijten +15 more
wiley +1 more source
Oncotransformation in Bhas 42 Cell Transformation Assay by Typical Non-Genotoxic Carcinogens, PFOA and PFOS, and Time-Course Transcriptome Analysis. [PDF]
Ohmori K.
europepmc +1 more source
Carcinogenicity Prediction of Schiff Base Ligand in Male Mice
Kamel Mokhnache +2 more
openalex +1 more source

